Aripiprazole recalls

The FDA has published 26 recalls involving Aripiprazole since 2013. The latest was reported on 24 Jun 2026. Most were for manufacturing (cgmp) deviations. Accord Healthcare has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls26since 2013

Last 12 months2reported

Class I00% of total

Ongoing7latest 24 Jun 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 1 0Oct 0 0 0Jan '26 0 0 0Apr 0 1 0Jul 0 0

Severity split

Class I 0 0%Class II 20 77%Class III 6 23%

Why aripiprazole is recalled

Companies

Accord Healthcare623%
Second Tokushima Factory, Otsuka Pharmaceutical Co415%
Apotex312%
Ascend Laboratories28%
Aidapak Services28%
The Harvard Drug Group28%
Ajanta Pharma USA14%
Bristol Myers Squibb Manufacturing14%

Brands

Aripiprazole1350%
Abilify519%

By year

202614%
202514%
2024519%
2023727%
202214%
2020415%
201828%
201728%
201428%
201314%

Ongoing aripiprazole recalls

7 active

Reported	Class	Recall	Company	Reason	Where
24 Jun 2026Drug	CLASS II	Aripiprazole Tablets recalled by Ajanta Pharma USAAripiprazole	Ajanta Pharma USA	Packaging Defects	Nationwide
24 Sep 2025Drug	CLASS II	Aripiprazole Tablets, USP, 10 mg recalled by Ascend LaboratoriesAripiprazole	Ascend Laboratories	Potency & Assay	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide

All aripiprazole recalls, newest first

26 total

Reported	Class	Recall	Company	Reason	Where
24 Jun 2026Drug	CLASS II	Aripiprazole Tablets recalled by Ajanta Pharma USAAripiprazole	Ajanta Pharma USA	Packaging Defects	Nationwide
24 Sep 2025Drug	CLASS II	Aripiprazole Tablets, USP, 10 mg recalled by Ascend LaboratoriesAripiprazole	Ascend Laboratories	Potency & Assay	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide
3 Jan 2024Drug	CLASS II	Aripiprazole Tablets, USP, 5 mg recalled by Cardinal HealthcareAripiprazole	Cardinal Healthcare	Manufacturing (CGMP) Deviations	Nationwide
26 Apr 2023Drug	CLASS II	Aripiprazole Tablets, USP, 20 mg recalled by Ascend LaboratoriesAripiprazole	Ascend Laboratories	Potency & Assay	Nationwide
8 Mar 2023Drug	CLASS II	Aripiprazole Tablets, USP 5 mg recalled by Accord HealthcareAripiprazole	Accord Healthcare	Manufacturing (CGMP) Deviations	PR
8 Mar 2023Drug	CLASS II	Aripiprazole Tablets, USP 30 mg recalled by Accord HealthcareAripiprazole	Accord Healthcare	Manufacturing (CGMP) Deviations	PR

Should you stop taking Aripiprazole?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.